BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

119 related articles for article (PubMed ID: 3992596)

  • 21. Preliminary crystallographic study of the Fab fragment of a monoclonal antibody directed against a cobra cardiotoxin.
    Guillon V; Alzari PM; Grognet JM
    J Mol Biol; 1986 Jun; 189(4):723-4. PubMed ID: 3783690
    [TBL] [Abstract][Full Text] [Related]  

  • 22. The status of tyrosyl residues in a Formosan cobra cardiotoxin.
    Hung MC; Pan YH; Cheng KL; Chen YH
    Biochim Biophys Acta; 1978 Aug; 535(2):178-87. PubMed ID: 28149
    [TBL] [Abstract][Full Text] [Related]  

  • 23. 1H nuclear-magnetic-resonance studies of the three-dimensional structure of the cardiotoxin CTXIIb from Naja mossambica mossambica in aqueous solution and comparison with the crystal structures of homologous toxins.
    Steinmetz WE; Bougis PE; Rochat H; Redwine OD; Braun W; Wüthrich K
    Eur J Biochem; 1988 Feb; 172(1):101-16. PubMed ID: 3345756
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Characterization of the anticoagulants from Taiwan cobra (Naja naja atra) snake venom.
    Teng CM; Kuo YP; Lee LG; Ouyang CH
    Toxicon; 1987; 25(2):201-10. PubMed ID: 3576637
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Factors in snake venoms that increase capillary permeability.
    Miller RA; Tu AT
    J Pharm Pharmacol; 1989 Nov; 41(11):792-4. PubMed ID: 2576052
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Production and characterization of monoclonal antibodies against Naja naja atra cobrotoxin.
    Stiles BG; Lidgerding BC; Sexton FW; Guest SB
    Toxicon; 1991; 29(10):1195-204. PubMed ID: 1724806
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Delineating residues for haemolytic activities of snake venom cardiotoxin 1 from Naja naja as probed by molecular dynamics simulations and in vitro validations.
    Gorai B; Sivaraman T
    Int J Biol Macromol; 2017 Feb; 95():1022-1036. PubMed ID: 27984143
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Monoclonal antibody specific for cyanoginosin-LA: preparation and characterization.
    Kfir R; Johannsen E; Botes DP
    Toxicon; 1986; 24(6):543-52. PubMed ID: 3750342
    [TBL] [Abstract][Full Text] [Related]  

  • 29. A simple method for purification of cardiotoxin from Indian cobra (Naja Naja Naja) venom.
    Chhatwal GS; Venkataraman A; Gaitonde BB
    Toxicon; 1978; 16(4):396-402. PubMed ID: 684770
    [No Abstract]   [Full Text] [Related]  

  • 30. Interactions in red blood cells between fatty acids and either snake venom cardiotoxin or halothane.
    Fletcher JE; Jiang MS; Tripolitis L; Smith LA; Beech J
    Toxicon; 1990; 28(6):657-67. PubMed ID: 2402762
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Expression of glutathione S-transferase-cardiotoxin fusion protein in Escherichia coli.
    Chi LM; Vyas AA; Rule GS; Wu WG
    Toxicon; 1994 Dec; 32(12):1679-83. PubMed ID: 7725337
    [TBL] [Abstract][Full Text] [Related]  

  • 32. cDNA sequence analysis and expression of cardiotoxin V and a new cardiotoxin VII from Naja naja atra (Taiwan cobra).
    Chang LS; Lin J; Wu PF
    Biochim Biophys Acta; 1996 Jun; 1295(1):1-4. PubMed ID: 8679666
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Production and characterization of monoclonal antibodies against stonustoxin from Synanceja horrida.
    Yuen R; Cai B; Khoo HE
    Toxicon; 1995 Dec; 33(12):1557-64. PubMed ID: 8866613
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Actions of cardiotoxins from the southern Chinese cobra (Naja naja atra) on rat cardiac tissue.
    Sun JJ; Walker MJ
    Toxicon; 1986; 24(3):233-45. PubMed ID: 3715895
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Purification and characterization of a myotoxic phospholipase A2 from Indian cobra (Naja naja naja) venom.
    Bhat MK; Gowda TV
    Toxicon; 1989; 27(8):861-73. PubMed ID: 2781585
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Localization of the toxic site of Naja mossambica cardiotoxins: small synthetic peptides express an in vivo lethality.
    Marchot P; Bougis PE; Ceard B; Van Rietschoten J; Rochat H
    Biochem Biophys Res Commun; 1988 Jun; 153(2):642-7. PubMed ID: 3382394
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Non-enzymatic inhibitors of coagulation and platelet aggregation from Naja nigricollis venom are cardiotoxins.
    Kini RM; Haar NC; Evans HJ
    Biochem Biophys Res Commun; 1988 Feb; 150(3):1012-6. PubMed ID: 3342055
    [TBL] [Abstract][Full Text] [Related]  

  • 38. A bioassay for cobra cardiotoxin activity using semi-isolated cockroach heart.
    Klowden MJ; Vitale AJ; Trumble MJ; Wesson CR; Trumble WR
    Toxicon; 1992 Mar; 30(3):295-301. PubMed ID: 1529463
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Circular dichroism study of the unfolding-refolding of a cardiotoxin from Taiwan cobra (Naja naja atra) venom.
    Gałat A; Yang CC; Blout ER
    Biochemistry; 1985 Sep; 24(20):5678-85. PubMed ID: 4074722
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Freeze-fracture study of cardiotoxin action on axonal membrane and axonal membrane lipid vesicles.
    Gulik-Krzywicki T; Balerna M; Vincent JP; Lazdunski M
    Biochim Biophys Acta; 1981 Apr; 643(1):101-14. PubMed ID: 7236681
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.